Bosentan Package Insert

Australian Public Assessment Report For Bosentan
Bosentan is an endothelin receptor antagonist currently registered in Australia for the A package insert is enclosed in the pack. This submission incorporates a proposal to widen to patient population by decreasing the ... Doc Viewer

MEDICAL POLICY STATEMENT - CareSource
(e.g., ambrisentan, bosentan, sildenafil, tadalafil) • Patient requires transition from epoprostenol. Refer to the product package insert for dosing, administration and safety guidelines. Conditions of Coverage. J-Code J3285 - treprostinil (Remodulin) ... Fetch Content

Drug Class Monograph Opsumit Revatio Tracleer Ventavis Line ...
Tracleer® (bosentan tablet) [Package Insert]. South San Francisco, CA: Actelion Pharmaceuticals US, Inc.; 2016. Change Control Date Change 02/15/2017 PDE -5 inhibitor (e.g. Revatio) is the preferred non formulary oral PAH agent for Orenitram and Uptravi ... Get Content Here

Treatment Of Pulmonary Arterial Hypertension With The ...
ULN with an ALT or AST 3 ULN. For OL bosentan patients, liver function abnormalities were handled accord-ing to the bosentan package insert, i.e., a patient was to be discontinued if ALT or AST exceeded 8 ULN, although the patient could undergo bosentan dosage reductions or temporary cessation for lesser elevations in ALT or AST at ... Fetch This Document

WHO Drug Information
WHO Drug Information Vol. 26, No. 1, 2012 world. This demands that the country’s regulatory activities are in line with international standards. Current efforts to reform health care inside China also pre-sent challenges for capacity building and regulation, while the quality and safety of services and products provided within the ... Return Document

Insulin Glargine - Wikipedia
Insulin glargine, marketed under the names Lantus, among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes.It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). ... Read Article

PACKAGE INSERT SCHEDULING STATUS PROPRIETARY NAME ... - Janssen
PACKAGE INSERT SCHEDULING STATUS Schedule 4 bosentan and certain non-nucleoside reverse inhibitors used in HIV treatments (e.g. nevirapine and efavirenz)]may interfere with the actions of EVOREL and decrease the efficacy of EVOREL. ... Get Document

Drug Interactions With Warfarin Med Cart Reference Guide Risk ...
Interactions with Coumadin [package insert]. Princeton, NJ: Bristol‐Myers Squibb; 2013. Drug Interactions with Warfarin Med Cart Reference Guide Increased Risk of Bleeding The following is a list of common medications that can increase a patient’s bleeding risk while on warfarin therapy. ... Get Document

THELIN (sitaxentan Sodium) Encysive Pharmaceuticals Inc. 100 ...
Label bosentan twice daily (efficacy-rater blinded, administered according to the approved package insert). Compared to THELIN 100 mg once daily, sitaxentan 50 mg once daily was ... Doc Retrieval

CASE REPORT Open Access Combined Use Of Ursodeoxycholic Acid ...
The package insert of bosentan indicates that the incidence of liver toxicity is 14.3% in Japanese clinical studies and 11% in US clinical * Correspondence: itot@hirakata.kmu.ac.jp First Department of Internal Medicine, Kansai Medical University, 2-5-1 ... Access Full Source

Pulmonary Arterial Hypertension Treatment Policy
Tracleer® (bosentan) Opsumit Please reference the package insert for more detailed drug information The World Health Organization (WHO) classifies pulmonary hypertension (PH) in five groups, based on underlying etiology of PH. Patients diagnosed with Group 1 pulmonary arterial hypertension ... Read Here

Omeprazole - Wikipedia
Omeprazole, sold under the brand names Prilosec and Losec among others, is a medication used in the treatment of gastroesophageal reflux disease, peptic ulcer disease, and Zollinger–Ellison syndrome. ... Read Article

TRACLEER - Vchealthcareplan.org
Description: TRACLEER is an endothelin receptor antagonist. Endothelin is a neurohormone which is elevated in the plasma and lung tissues of patients with pulmonary arterial hypertension (PAH). Authorization Criteria: Treatment of pulmonary arterial hypertension (PAH) (WHO Group I) ... Read Full Source

Phenytoin - Wikipedia
Phenytoin (PHT), sold under the brand name Dilantin among others, is an anti-seizure medication. It is useful for the prevention of tonic-clonic seizures and partial seizures, but not absence seizures. ... Read Article

Www.tyvaso.com
Controlled clinical experience with inhaled treprostinil has been on a background of bosentan (an endothelin receptor antagonist) or sildenafil (a phosphodiesterase type 5 inhibitor). The controlled clinical experience was limited to 12 weeks in duration [see Clinical Studies (14)]. ... Return Document

Michael Schirmer, Pharm.D., BCPS Clinical Pharmacist ...
Contraindicated: cyclosporine ( bosentan), glyburide ( hepatotoxicity) simvastatin, warfarin, oral contraceptives, sildenafil ( bosentan) Tacrolimus may bosentan Ritonavir bosentan, requires dose adjustments Contraindications Moderate-severe hepatic impairment Pregnancy Tracleer [package insert]. ... Retrieve Content

UPMC Health Plan POLICY AND PROCEDURE MANUAL
UPMC Health Plan POLICY AND PROCEDURE MANUAL POLICY NUMBER: RX-PA.076 REVISION DATE: 04/2008 (bosentan) a. Member has a confirmed diagnosis of PAH with WHO functional class III 1. Ventavis [package insert]. South San Francisco, CA: CoTherix, Inc.; December 2004. 2. Wickersham RM, Novak ... Retrieve Content

National PBM Monograph Template Rev20091005
TyvasoTM (Treprostinil) inhalation solution patient package insert. United Therapeutics Corp., Research Triangle Park, NC. July 2009. McLaughlin VV, Benza RL, Rubin LJ, et al. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. ... Fetch Full Source

Dialysis Of Drugs Source Documents Last Updated September 17 ...
Abelcet package insert (2007) Ampicillin/sulbactam Blum RA, et al. Pharmacokinetics of ampicillin and sulbactam coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis. Antimicrob Agents Chemother 1989, 33, 1470-6. (2013) Amprenavir Agenerase package insert (2000) Amsacrine ... Visit Document